# 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

> **NCT06349512** · NA · RECRUITING · sponsor: **Institut Curie** · enrollment: 60 (estimated)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **PROCEDURE:** 68Ga-FAPI-46 PET/CT imaging

## Key facts

- **NCT ID:** NCT06349512
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-14
- **Primary completion:** 2032-11-30
- **Final completion:** 2032-11-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06349512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06349512, "68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06349512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*